Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2070 of 5804
-
Harmonica breathing: a fun way to ease COPD symptoms?
Symptom relief Completed15 patients who have completed the Baylor Martha Foster Lung Center Pulmonary Rehabilitation Program at least six months ago will be selected to participate in a 12 week training program with six months of follow up.
Phase: NA • Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Radioactive beads show promise for liver tumors in french registry
Disease control CompletedSelective Internal Radiation Therapy (SIRT), also known as radioembolisation, is a minimal invasive, endovascular treatment for primary and secondary liver tumours. In France, SIR-Spheres are listed as reimbursable by the national health authorities (Haute Autorité de Santé \[HAS…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo drug aims to cut opioid use after hernia surgery
Symptom relief CompletedThis is a Phase 3, randomized, double-blind, saline placebo- and active-controlled, multicenter study to evaluate the analgesic efficacy and safety of HTX 011 administered via local administration into the surgical site in subjects undergoing unilateral open inguinal herniorrhaph…
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Could a cancer drug tame rare overgrowth disease?
Disease control TerminatedSegmental overgrowth disorders are rare conditions characterised by abnormal growth which is usually asymmetric and confined to discrete parts of the body. We and others have identified mosaic activating mutations in the p110α catalytic subunit of phosphatidylinositol-3-kinase (P…
Phase: PHASE1, PHASE2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Cochlear implant boosts hearing in One-Eared hearing loss
Symptom relief CompletedThis longitudinal study evaluates the possible benefit of cochlear implantation in the poor ear of adults with asymmetric hearing loss who continue to use a hearing aid in the better hearing ear.
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a smartphone replace the nurse? study tests video monitoring for TB treatment
Disease control CompletedThis study is a U.S.-based, 1 site (with 4 clinical settings), randomized controlled trial (with funding from the Centers for Disease Control and Prevention's (CDC) Antibiotic Resistance Solutions Initiative) that will be implemented to evaluate traditional directly observed ther…
Phase: NA • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New heart valve passes safety check in 57 patients
Disease control CompletedThis study will confirm the safety and effectiveness of the Edwards Lifesciences SAPIEN XT Transcatheter Heart Valve (THV) System in patients with a dysfunctional right ventricular outflow tract (RVOT) conduit with a clinical indication for intervention in a post-market setting.
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Blood samples may unlock secrets of a common epilepsy
Knowledge-focused Recruiting nowThe investigators are collecting genetic information through blood samples as well as clinical and EEG data from over 1000 people with Juvenile Myoclonic Epilepsy (JME) across the UK, Europe and North America. This study will draw on both existing and new samples from JME patient…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:04 UTC
-
Could a cancer drug shrink recurrent brain tumors?
Disease control OngoingThe purpose of this study is to test any good and bad effects of a study drug called abemaciclib (LY2835219) in patients with recurrent brain tumors.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug shows promise for rare hormone disorder
Disease control CompletedThis is a multicenter Phase 2, multiple dose, dose escalation study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of SPR001 in adult patients with classic congenital adrenal hyperplasia (CAH).
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
IVF hormone Add-On shows promise for live births
Disease control CompletedThe aim of this study is to test the hypothesis that addition of daily small dose of human menopausal gonadotropin (HMG) drug following oocytes retrieval could improve the fertility outcome in women undergoing in-vitro fertilization
Phase: PHASE4 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Brain activity may reveal who responds best to CBT for depression and anxiety
Knowledge-focused CompletedMany patients with Major Depressive Disorder (MDD) and generalized Social Anxiety Disorder (gSAD) are treated with cognitive behavioral therapy (CBT) but few have meaningful improvement. MDD and gSAD are diseases of brain dysfunction that manifest as impaired emotion regulation; …
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Cancer patients get continued access to promising targeted therapy
Disease control CompletedThe purpose of this study is to provide continued treatment with alectinib or crizotinib as applicable to participants with ALK- or RET positive cancer who were previously enrolled in any Roche-sponsored alectinib study and who are deriving continued clinical benefit from alectin…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Stent showdown: which device heals arteries better after a heart attack?
Disease control CompletedThis study aims to compare the acute thrombogenecity and frequency of neoatherosclerotic lesions and other aspects of long term arterial healing such as the frequency of malapposed and uncovered stent struts at 3 years among patients treated with either a biodegradable polymer ev…
Phase: NA • Sponsor: Tokorozawa Heart Center • Aim: Disease control
Last updated Jun 26, 2026 14:28 UTC
-
Could a malaria drug help kids with rare lung disease?
Disease control CompletedThe purpose of this proposed research is to investigate the efficacy and safety of hydroxychloroquine sulfate (HCQ, Quensyl) for pediatric ILD(chILD) caused by pulmonary surfactant-associated genes mutations.
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New bone graft could improve spine surgery outcomes
Disease control OngoingThe purpose of this study is to obtain safety and effectiveness data on the investigational device for multi-level PLF procedures and determine the most appropriate rhBMP-2 dose for use in this indication. The study information may be used for a potential pivotal study design.
Phase: NA • Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Texts and talks: a new push to get Mexican-American teens vaccinated against HPV
Prevention OngoingThis study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans. The …
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Could a stem cell 'Education' help tame type 1 diabetes?
Disease control CompletedThis is a prospective, single arm, open-label, single-center pilot study to assess the safety, feasibility, and efficacy of Stem Cell Educator therapy for the treatment of patients with Type 1 Diabetes.
Phase: PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for advanced cancer: Immune-Boosting drug combo tested in japan
Disease control OngoingPart 2 Cohorts A and C This study is being conducted to test the safety and pharmacokinetics of cemiplimab in patients with lung cancer. The study is also being conducted to test if cemiplimab, alone or in combination, can reduce the size of your tumor by helping the immune syste…
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New oral drug targets Cancer's growth engine in advanced tumours
Disease control CompletedThis clinical study looked at a drug called LY3143921 hydrate (a Cdc7 inhibitor) in adult patients with advanced solid tumours. The main aims were to find out the maximum dose of LY3143921 hydrate that could be given safely to patients, and to assess the potential side effects an…
Phase: PHASE1 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC